Identification of human T cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Identification of human T cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil.

AIDS Res Hum Retroviruses. 1995 Jul;11(7):813-21. Unique Identifier : AIDSLINE GENBANK/U19109
Ishak R; Harrington WJ Jr; Azevedo VN; Eiraku N; Ishak MO; Guerreiro JF; Santos SB; Kubo T; Monken C; Alexander S; et al; Federal University of Para, Belem, Brazil.

Abstract: Human T cell lymphotropic virus type II (HTLV-II) infection is endemic in a number of indigenous populations in North, Central, and South America. In the present study we have employed serological and molecular methods to identify HTLV-II infection in Indian communities in the Amazon region of Brazil. Sera (1324) from 25 different Indian communities were analyzed by ELISA and Western blot. One hundred and four samples (7.8%) from a number of culturally distinct and geographically unrelated populations were found to have reactivities consistent with HTLV-II infection. Of these, 67 were from the Kayapo Indian communities, which had an overall seroprevalence rate of greater than 30%. In addition, high seroprevalence rates were observed in three other communities, the Munduruku, Arara do Laranjal and the Tyrio, suggesting that there are additional foci of endemic infection in the Amazon region. In the Kayapo, seroprevalence rates tended to increase with age, supporting the importance of sexual transmission of the virus, and family studies demonstrated that vertical transmission is also an important route of infection. Restriction fragment length polymorphism (RFLP) and nucleotide sequence analysis of a region of the env gene demonstrated that the Kayapo are infected with the HTLV-IIa subtype. Moreover, nucleotide sequence analysis of the LTR demonstrated that this belonged to a distinct HTLV-IIa phylogenetic group. The identification of HTLV-IIa in the Kayapo is, as far as we are aware, the first identified endemic focus of infection by this subtype of HTLV-II in the Americas.
Keywords: Adolescence Adult Age Factors Aged Base Sequence Blotting, Western Brazil/EPIDEMIOLOGY Child Child, Preschool Comparative Study Disease Transmission, Vertical DNA Primers Female *Genes, env Geography Human HTLV-II/CLASSIFICATION/*GENETICS/ISOLATION & PURIF HTLV-II Antibodies/*BLOOD HTLV-II Infections/*EPIDEMIOLOGY/TRANSMISSION Indians, South American/*STATISTICS & NUMER DATA Infant Infant, Newborn Male Middle Age Molecular Sequence Data Pedigree Phylogeny Polymerase Chain Reaction Polymorphism, Restriction Fragment Length Prevalence Sex Characteristics Sex Factors Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE

KWDadolescenceadultagefactorsagedbasesequenceblotting,westernbrazil/epidemiologychildchild,preschoolcomparativestudydiseasetransmission,verticaldnaprimersfemaleKWDgenes,envgeographyhumanhtlv-ii/classification/KWDgenetics/isolation&purifhtlv-iiantibodies/KWDbloodhtlv-iiinfections/KWDepidemiology/transmissionindians,southamerican/KWDstatistics&numerdatainfantinfant,newbornmalemiddleagemolecularsequencedatapedigreephylogenypolymerasechainreactionpolymorphism,restrictionfragmentlengthprevalencesexcharacteristicssexfactorssupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDjournalarticle
960130
M9610754

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .